William Ho
2020 - IN8BIO
In 2020, William Ho earned a total compensation of $1.4M as President and Chief Executive Officer at IN8BIO.
Compensation breakdown
| Bonus | $150,000 |
|---|---|
| Non-Equity Incentive Plan | $144,000 |
| Option Awards | $874,540 |
| Salary | $279,167 |
| Total | $1,447,707 |
Ho received $874.5K in option awards, accounting for 60% of the total pay in 2020.
Ho also received $150K in bonus, $144K in non-equity incentive plan and $279.2K in salary.
Rankings
In 2020, William Ho's compensation ranked 6,978th out of 13,090 executives tracked by ExecPay. In other words, Ho earned more than 46.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,978 out of 13,090 | 47th |
Division Manufacturing | 2,908 out of 5,621 | 48th |
Major group Chemicals And Allied Products | 1,175 out of 2,254 | 48th |
Industry group Drugs | 1,012 out of 1,954 | 48th |
Industry Biological Products, Except Diagnostic Substances | 242 out of 411 | 41st |
Source: SEC filing on April 22, 2022.
Ho's colleagues
We found one more compensation record of an executive who worked with William Ho at IN8BIO in 2020.
2020
Lawrence Lamb
IN8BIO
Chief Scientific Officer
News
RAPT Therapeutics CEO Brian Wong's 2023 pay jumps 26% to $6.6M
April 5, 2024
RAPT Therapeutics CEO Brian Wong's 2022 pay jumps 84% to $5.2M
April 7, 2023
IN8BIO CEO William Ho's 2021 pay jumps 51% to $2.3M
April 22, 2022
RAPT Therapeutics CEO Brian Wong's 2021 pay falls 21% to $2.8M
April 11, 2022
RAPT Therapeutics CEO Brian Wong's 2020 pay jumps 86% to $3.6M
April 15, 2021
RAPT Therapeutics CFO Rodney Young receives $2.3M in 2019
April 29, 2020